
Millions of people use weight loss drugs – but half of patients stop taking them within one year, according to a new analysis.
Popular anti-obesity and diabetes medicines such as Ozempic and Wegovy are part of a class of drugs known as glucagon-like peptide-1 (GLP-1) receptor agonists, which help people lose weight by mimicking a hormone that reduces their appetite.